跳至主要内容
临床试验/EUCTR2006-000369-12-DE
EUCTR2006-000369-12-DE进行中(未招募)不适用

An open, randomized, single-center study assessing the serum time-concentration curves and the effect of prophylactic moxifloxacin (in comparison with cefuroxime) on the early inflammatory response to cardiopulmonary bypass in patients undergoing coronary artery bypass grafting - Moxi and CPB

Institute of Anaesthesiology, German Heart Centre0 个研究点目标入组 30 人开始时间: 2006年3月6日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • coronary artery disease scheduled for coronary artery bypass grafting with cardiopulmonary bypass
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • - Body mass index > 30
  • - Ejection fraction < 50 %
  • - Severe cardiac arrhythmias (long QT syndrome) or intake of drugs which prolong the QT interval (available from: http://www.torsades.org)
  • - Renal and hepatic dysfunction, evaluated by serum creatinine and SGOT/SGPT values above the normal range
  • - Intake of corticosteroids
  • - Allergies to quinolones, cephalosporins, aprotinin, or other drugs leading to the decision to omit these drugs or to give prophylactic antihistamines and corticosteroids
  • - Antibiotic therapy or infectious disease until 2 weeks before start of the trial
  • - Women who are pregnant (women with childbearing potential must have a negative pregnancy test) and nursing mothers
  • - Tendinopathies caused by quinolones
  • - Seizures

研究者

发起方
Institute of Anaesthesiology, German Heart Centre

相似试验